{"id":24475,"date":"2025-04-13T17:41:48","date_gmt":"2025-04-13T17:41:48","guid":{"rendered":"https:\/\/researchchemicallab.eu\/?post_type=product&#038;p=24475"},"modified":"2026-02-02T19:15:52","modified_gmt":"2026-02-02T19:15:52","slug":"kjop-4-fma","status":"publish","type":"product","link":"https:\/\/researchchemicallab.eu\/nb\/butikk\/kjop-4fma\/kjop-4-fma\/","title":{"rendered":"4-Fluor 4-FMA 120 MG pellets"},"content":{"rendered":"<h2 class=\"ds-markdown-paragraph\"><strong>4-Fluor 4-FMA 120 mg pellets \u2013 Avansert forskningsstimulant<\/strong><\/h2>\n<h3><strong>Produktdefinisjon<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">kj\u00f8p 4 fma, <strong>4-Fluor 4-FMA 120 mg pellets<\/strong>\u00a0inneholde en\u00a0<strong>fluoramfetaminderivat med h\u00f8y renhet<\/strong>, spesielt utviklet for\u00a0<strong>nevrofarmakologisk forskning p\u00e5 dopamin og serotonerge systemer<\/strong>.<\/p>\n<p class=\"ds-markdown-paragraph\">\u2714\u00a0<strong>120 mg presisjonsdosering<\/strong>\u00a0per pellet<br \/>\n\u2714\u00a0<strong>Farmas\u00f8ytisk kvalitet<\/strong>\u00a0(GMP-sertifisert)<br \/>\n\u2714\u00a0<strong>Optimalisert oral absorpsjon<\/strong><br \/>\n\u2714\u00a0<strong>Varmebestandig belegg<\/strong>\u00a0(opptil 40 \u00b0C)<\/p>\n<hr \/>\n<h2><strong>Sammendrag av laboratorierapport (COA)<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\">*Batch #4FMA-0927-NL | Testet av StimScience Analytics*<br \/>\n\u2714\u00a0<strong>120,5 mg \u00b11,5 mg per pellet<\/strong>\u00a0(HPLC-MS)<br \/>\n\u2714\u00a0<strong>98,9% kjemisk renhet<\/strong><br \/>\n\u2714\u00a0<strong>Ingen spor av 4-FA eller amfetamin<\/strong>\u00a0(&lt;0,05%)<br \/>\n\u2714\u00a0<strong>Mikrobiologisk sikkerhet<\/strong>i samsvar med EP 2.6.13<\/p>\n<hr \/>\n<h2><strong>Bruksomr\u00e5der<\/strong><\/h2>\n<h3><strong>1. Nevrokjemisk unders\u00f8kelse<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">SERT\/DAT\/NET transporter hemming<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Sammenlignende studier med MDMA<\/p>\n<\/li>\n<\/ul>\n<h3><strong>2. Atferdsfarmakologi<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">Selvadministrasjonsparadigmer<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Modeller for sosial interaksjon<\/p>\n<\/li>\n<\/ul>\n<h3><strong>3. Toksikologisk unders\u00f8kelse<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">Screening av nevrotoksiske effekter<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Risikovurdering av hypertermi<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Bruksprotokoll<\/strong><\/h2>\n<h3><strong>Standardadministrasjon<\/strong><\/h3>\n<ol start=\"1\">\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Muntlig<\/strong>1 pellet med 10 ml vann<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Observasjonsperiode<\/strong>: 6\u20138 timer<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Doseintervall<\/strong>Minimum 1 uke<\/p>\n<\/li>\n<\/ol>\n<h3><strong>Alternative metoder<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Sublingual<\/strong>Knus mellom sterile glassplater<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>L\u00f8s opp til injeksjon<\/strong>24 mg\/ml i steril saltl\u00f8sning<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Fordeler<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\">\u2713\u00a0<strong>Lengre virkningsvarighet<\/strong>\u00a0(8\u201310 timer) deretter 4-FA<br \/>\n\u2713\u00a0<strong>Balansert DA\/SERT-aktivitet<\/strong><br \/>\n\u2713\u00a0<strong>Mindre kardiovaskul\u00e6r stress<\/strong>\u00a0enn MDMA<br \/>\n\u2713\u00a0<strong>Ideell for langsiktige atferdseksperimenter<\/strong><\/p>\n<h2><strong>Ulemper<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\">\u26a0\u00a0<strong>Potensiell nevrotoksisitet<\/strong>\u00a0med gjentatt bruk<br \/>\n\u26a0\u00a0<strong>Risiko for serotoninsyndrom<\/strong><br \/>\n\u26a0\u00a0<strong>Juridisk status<\/strong>Opiumlovens tillegg I (NL)<br \/>\n\u26a0\u00a0<strong>Temperaturf\u00f8lsomhet<\/strong>\u00a0(oppbevares ved 15\u201325 \u00b0C)<\/p>\n<hr \/>\n<h2><strong>Ofte stilte sp\u00f8rsm\u00e5l (FAQ)<\/strong><\/h2>\n<h3><strong>Sp\u00f8rsm\u00e5l: Hvordan er 4-FMA sammenlignet med 3-FMA?<\/strong><\/h3>\n<div class=\"markdown-table-wrapper\">\n<table>\n<thead>\n<tr>\n<th>Parameter<\/th>\n<th>4-FMA<\/th>\n<th>3-FMA<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Potensiell<\/td>\n<td>\u2605\u2605\u2605\u2606<\/td>\n<td>\u2605\u2605\u2606\u2606<\/td>\n<\/tr>\n<tr>\n<td>Virkningsvarighet<\/td>\n<td>8\u201310<\/td>\n<td>6\u20138<\/td>\n<\/tr>\n<tr>\n<td>SERT-selektivitet<\/td>\n<td>65%<\/td>\n<td>40%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h3><strong>Sp\u00f8rsm\u00e5l: Kan jeg administrere pellets nasalt?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">EN:\u00a0<strong>Ikke anbefalt<\/strong>\u00a0\u2013 Optimalisert for oral bruk<\/p>\n<h3><strong>Q: Egnet for mikrodosering?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">EN:\u00a0<strong>Begrenset<\/strong>\u00a0\u2013 Start med 1\/4 pellet (30 mg)<\/p>\n<h3><strong>Sp\u00f8rsm\u00e5l: Hva om jeg f\u00e5r en utilsiktet overdose?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">A: Stopp umiddelbart + benzodiazepinprotokoll<\/p>\n<hr \/>\n<h2><strong>Sikkerhetstiltak<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\">\u2022\u00a0<strong>EKG-overv\u00e5king<\/strong>\u00a0forpliktet<br \/>\n\u2022\u00a0<strong>Temperaturregistrering<\/strong>\u00a0(risiko for hypertermi)<br \/>\n\u2022\u00a0<strong>Hydreringsprotokoll<\/strong><\/p>\n<p class=\"ds-markdown-paragraph\">*Ansvarsfraskrivelse: Kun for legitim vitenskapelig forskning. Ikke for menneskelig bruk. Kun for personer over 21 \u00e5r. Lagre l\u00e5st.*<\/p>\n<hr \/>\n<p class=\"ds-markdown-paragraph\"><strong>\ud83d\udd2c Fullstendig analytisk rapport?<\/strong>\u00a0Skann QR-koden<\/p>\n<p class=\"ds-markdown-paragraph\"><em>Merk: R\u00e5df\u00f8r deg alltid med en toksikolog for protokoller.<\/em><\/p>\n<hr \/>\n<h3><strong>Forskningstjeneste<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">Ved bestilling av &gt;50 pellets:<br \/>\n\u2713\u00a0<strong>Gratis nevrotoksisitetsprotokoll<\/strong><br \/>\n\u2713\u00a0<strong>Tilgang til reseptorbindingsdata<\/strong><\/p>\n<hr \/>\n<p class=\"ds-markdown-paragraph\"><strong>JURIDISK ADVARSEL:<\/strong>\u00a0Dette produktet krever spesielle forskningstillatelser. Besittelse uten tillatelse er straffbart ved lov.<\/p>\n<hr \/>\n<h3><strong>Anbefalt dosering (dyrestudier)<\/strong><\/h3>\n<div class=\"markdown-table-wrapper\">\n<table>\n<thead>\n<tr>\n<th>Modell<\/th>\n<th>Startdose<\/th>\n<th>Maksimal dose<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Mus<\/td>\n<td>12 mg\/kg<\/td>\n<td>48 mg\/kg<\/td>\n<\/tr>\n<tr>\n<td>Rotter<\/td>\n<td>6 mg\/kg<\/td>\n<td>24 mg\/kg<\/td>\n<\/tr>\n<tr>\n<td>Primater<\/td>\n<td>2,4 mg\/kg<\/td>\n<td>9,6 mg\/kg<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\"><strong>ETISKE RETNINGSLINJER:<\/strong>\u00a0All dyrefors\u00f8k m\u00e5 v\u00e6re i samsvar med\u00a0<strong>Lov om dyrefors\u00f8k<\/strong>. <a href=\"https:\/\/researchchemicallab.eu\/nb\/butikk\/lysergamider\/1vlsd\/\">1vlsd<\/a><a href=\"https:\/\/researchchemicallab.eu\/nb\/butikk\/pellets-for-pellets\/o-dsmt-50-mg-pellets\/\">o-dsmt<\/a><a href=\"https:\/\/researchchemicallab.eu\/nb\/butikk\/iboga-ibogain\/kjop-ibogaine-hcl-pa-nett\/\">kj\u00f8p ibogaine hcl p\u00e5 nett<\/a><a href=\"https:\/\/researchchemicallab.eu\/nb\/butikk\/iboga-ibogain\/iboga-rotbark\/\">iboga rotbark<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>4-Fluor 4-FMA 120 mg pellets \u2013 Advanced Research Stimulant Produktdefinisjon Kj\u00f8p 4 fma, 4-Fluor 4-FMA 120 mg pellets inneholder et fluoramfetaminderivat med h\u00f8y renhet, spesielt utviklet<\/p>","protected":false},"featured_media":28944,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[459,460,322,333,324],"product_tag":[629,326],"class_list":{"0":"post-24475","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-4fma-kopen","7":"product_cat-4-fma-pellets","8":"product_cat-bijna-verboden","9":"product_cat-gefluoreerden","10":"product_cat-pellets-for-pellet","11":"product_tag-4-fma-kopen","12":"product_tag-nl","14":"first","15":"instock","16":"taxable","17":"shipping-taxable","18":"purchasable","19":"product-type-variable"},"_links":{"self":[{"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/product\/24475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/comments?post=24475"}],"version-history":[{"count":4,"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/product\/24475\/revisions"}],"predecessor-version":[{"id":26481,"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/product\/24475\/revisions\/26481"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/media\/28944"}],"wp:attachment":[{"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/media?parent=24475"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/product_brand?post=24475"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/product_cat?post=24475"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/researchchemicallab.eu\/nb\/wp-json\/wp\/v2\/product_tag?post=24475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}